STEM Times Arkansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.

Press releases published on October 26, 2026

Oct. 26, 2026

Dot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directors

Indeterminate GlobeNewswire

Oct. 26, 2026

MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer

Indeterminate GlobeNewswire

Oct. 26, 2026

Serapha Bio Announces Positive Interim Safety and Efficacy Data from the SERP-01 Investigator-Initiated Trial Presented at the ERS Alpha-1 Antitrypsin Conference 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator

Indeterminate GlobeNewswire

Oct. 26, 2026

Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness

Indeterminate GlobeNewswire

Oct. 26, 2026

Xtract One Technologies to Present at Planet MicroCap Toronto 2026 Powered by MicroCapClub

Indeterminate GlobeNewswire

Oct. 26, 2026

Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

TILT Biotherapeutics Presents Encouraging Phase 1b Results in Ovarian Cancer at ESMO 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

VETmAb Biosciences Announces Positive Clinical Proof-of-Concept Results for Long-Acting Anti-IL-23 Antibody in Canine Chronic Inflammatory Enteropathy

Indeterminate GlobeNewswire

Oct. 26, 2026

Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Oct. 26, 2026

Harrow To Report Third Quarter 2026 Financial Results After Market Close on November 9, 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 26, 2026

Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis

Indeterminate GlobeNewswire

Oct. 26, 2026

BPGbio Presents Phase 2 Glioblastoma Data Update at ESMO Congress 2026, Highlighting Median Overall Survival of 19.9 Months in MGMT-Unmethylated Patients

Indeterminate GlobeNewswire

Oct. 26, 2026

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine

Indeterminate GlobeNewswire

Oct. 26, 2026

Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

EarthDaily Awarded $3 Million NASA Task Order to Advance Commercial Earth Observation Integration with Landsat

Indeterminate GlobeNewswire